Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Jon Summers at [email protected].

  • March 14, 2022

    New Survey: Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

    A new UsAgainstAlzheimer’s A-LIST® survey of people with Alzheimer’s and Alzheimer’s caregivers shows that...

    Read more
  • March 11, 2022

    UsAgainstAlzheimer’s Applauds U.S. Senate for Passing Federal Funding Bill That Makes Significant Investments in the Fight to End Alzheimer’s

    In a tremendous victory for Alzheimer’s advocates, the United States Senate passed...

    Read more
  • March 10, 2022

    New Federal Spending Bill Includes Robust Investments in Alzheimer’s Prevention and Research

    UsAgainstAlzheimer’s applauds the House-passed bill to fund the federal government that includes...

    Read more
  • March 02, 2022

    Statement from UsAgainstAlzheimer’s Regarding President Biden’s State of the Union Remarks on Paid Family Leave

    In response to President Joe Biden’s State of the Union remarks regarding Paid Family Leave, ...

    Read more
  • March 01, 2022

    Statement from UsAgainstAlzheimer’s Regarding President Biden’s State of the Union Remarks on ARPA-H

    In response to President Joe Biden’s State of the Union remarks regarding...

    Read more
  • March 01, 2022

    Collins, Capito Urge CMS to Ensure Alzheimer’s Coverage Decision Does Not Restrict Access, Impede Research

    In January, the Centers for Medicare and Medicaid Services (CMS) released a...

    Read more
  • February 15, 2022

    UsAgainstAlzheimer’s Congratulates Dr. Robert Califf on Confirmation as New FDA Commissioner by U.S. Senate

    Today, the United States Senate confirmed Dr. Robert Califf as the new...

    Read more
  • February 10, 2022

    Leading Clinicians and Researchers Raise Significant Concerns about Medicare Plan to Effectively Deny Access to Alzheimer’s Treatments

    Many of the nation’s top Alzheimer’s clinicians and researchers called for the...

    Read more
  • February 10, 2022

    UsAgainstAlzheimer’s Urges CMS to Revise Plan that would Deny Medicare Coverage of FDA-approved Alzheimer’s Drugs

    A proposed plan that effectively would deny Medicare coverage for an entire...

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.

Read Report